Thyroid hormone receptor antagonist and cholesterol absorption inhibitor
This page covers all Thyroid hormone receptor antagonist and cholesterol absorption inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Thyroid hormone receptor.
Targets
Phase 2 pipeline (1)
- Eprotirome and ezetimibe · Karo Bio AB · Cardiovascular
Eprotirome is a thyroid hormone receptor antagonist, and ezetimibe is a cholesterol absorption inhibitor.